High glucose levels in cancer patients increase the flux into HBP and improve GFAT enzyme levels (Vasconcelos-Dos-Santos et al., 2017), resulting in increased GFAT activity and inhibited glucose uptake and glycogen synthesis in insulin-resistant patients (Srinivasan et al., 2007). The gene discussed is GFPT2; the disease is cancer.